OR13-05 Longitudinal Changes In Bone Turnover Following Withdrawal Of RANKL Inhibition

Disclosure: A.S. Kim: None. A. Castro-Martinez: None. V. Taylor: None. J. Center: None. C.M. Girgis: None. P.I. Croucher: None. M.M. Mcdonald: None. Denosumab is an effective osteoporosis treatment, preventing bone loss by inhibiting RANKL. However, stopping denosumab leads to rebound bone mineral d...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Albert S, Castro-Martinez, Ariel, Taylor, Victoria, Center, Jacqueline, Girgis, Christian M, Croucher, Peter I, Mcdonald, Michelle M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Bone And Mineral Metabolism
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10555373/
http://dx.doi.org/10.1210/jendso/bvad114.472

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10555373/
http://dx.doi.org/10.1210/jendso/bvad114.472

Ejemplares similares